ACM
IONS icon

Avalon Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Avalon Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-49,999
Closed -$1.99M – 112
2013
Q4 		$1.99M Sell
49,999
-944
-2% -$33.6K 1.68% 14
2013
Q3 		$1.91M Buy
50,943
+21,568
+73% +$644K 1.89% 13
2013
Q2 		$789K Buy
+29,375
New +$625K 0.78% 42

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avalon Capital Management's IONS Position: Q1 2014 in Review

Avalon Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2014, closing a stake of 49,999 shares — an estimated $1.99M sold.

Avalon Capital Management first reported a position in IONS in Q2 2013 and held it in 3 quarters. The position peaked at $1.99M in Q4 2013. 234 funds tracked by Wall St. Rank hold IONS as of Q1 2014.

  • Avalon Capital Management reported no remaining Ionis Pharmaceuticals position as of Q1 2014 after selling out during the quarter.
  • Avalon Capital Management sold 49,999 Ionis Pharmaceuticals shares in Q1 2014, an estimated $1.99M.
  • Avalon Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 3 quarters.
  • Avalon Capital Management's Ionis Pharmaceuticals position peaked at $1.99M in Q4 2013.
  • 234 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2014.

Based on Avalon Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.